3IDX image
Entry Detail
PDB ID:
3IDX
Keywords:
Title:
Crystal structure of HIV-gp120 core in complex with CD4-binding site antibody b13, space group C222
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2009-07-22
Release Date:
2009-11-17
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.23
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
C 2 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:HIV-1 HxBc2 gp120 core
Mutations:M95W, T257S, S375W, A443M, W96C, V275C, I109C, Q428C
Chain IDs:A (auth: G)
Chain Length:317
Number of Molecules:1
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Description:Fab b13 heavy chain
Chain IDs:B (auth: H)
Chain Length:231
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Fab b13 light chain
Chain IDs:C (auth: L)
Chain Length:215
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
Science 326 1123 1127 (2009)
PMID: 19965434 DOI: 10.1126/science.1175868

Abstact

The site on HIV-1 gp120 that binds to the CD4 receptor is vulnerable to antibodies. However, most antibodies that interact with this site cannot neutralize HIV-1. To understand the basis of this resistance, we determined co-crystal structures for two poorly neutralizing, CD4-binding site (CD4BS) antibodies, F105 and b13, in complexes with gp120. Both antibodies exhibited approach angles to gp120 similar to those of CD4 and a rare, broadly neutralizing CD4BS antibody, b12. Slight differences in recognition, however, resulted in substantial differences in F105- and b13-bound conformations relative to b12-bound gp120. Modeling and binding experiments revealed these conformations to be poorly compatible with the viral spike. This incompatibility, the consequence of slight differences in CD4BS recognition, renders HIV-1 resistant to all but the most accurately targeted antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures